Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK takes £2.2bn hit from Avandia claims

January 18, 2011 Sales and Marketing Avandia, GSK, GlaxoSmithKline, rosiglitazone

GlaxoSmithKline’s Avandia woes are continuing, with the company admitting it expects to take a mammoth legal charge over the troubled …
Sanofi-Aventis' Multaq (dronedarone)

FDA issues Multaq liver warning

January 17, 2011 Sales and Marketing FDA, Multaq, atrial fibrilation, dronedarone

US regulators have warned doctors and patients about the risk of severe liver injury associated with Sanofi-Aventis’ atrial fibrillation (AF) …
Blog footer

Digital Pharma: Sanofi launches diabetes blog

January 17, 2011 Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes

Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …

Roche finance chief steps down

January 17, 2011 Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing

Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …

Watermeadow supports charity cycle ride

January 13, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …
Pfizer's Lipitor tablet

Pfizer lung cancer drug gets ‘rolling’ fast-track status in US

January 13, 2011 Sales and Marketing Cancer, NSCLC, axitinib, bosutinib, crizotinib, non-small cell lung cancer

Pfizer has initiated a ‘rolling’ submission for its new oral ALK lung cancer drug crizotinib that could see it on …

Czech reforms will cut drug spending

January 13, 2011 Sales and Marketing Czech Republic, Drug pricing, drug funding, drug spending, global pricing, healthcare reforms, medicines pricing

The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …

Marketing authorisations for medicines: UK Decentralised Procedure slots available in all therapeutic areas in 2011

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The MHRA has reported it has RMS decentralised procedure slots available in 2011 for all therapeutic areas, including biologicals and …

Servier’s Mediator provokes French drug safety controversy

January 12, 2011 Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety

Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …

Regulatory assistance available to Small and Medium-sized Enterprises (SMEs)

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product …

Deadline approaching for cancelling UK Licences

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The MHRA has recently advised all holders of UK marketing authorisations, registrations and licences to inform them by the 31st …

Updated report on origins of clinical trial participants

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency has published an updated report detailing the geographical origins of patients included in clinical trials for …

Scientific Advice and Guidance Available

January 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In April, we reported how a joint pilot scheme operated by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), …
ABPI

UK trade associations form new life sciences lobbying group

January 11, 2011 Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying

Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …

Savient plays down gout drug manufacturing problems

January 11, 2011 Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase

Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …
The Gateway to Local Adoption Series

Latest content